{"title":"Sprawozdanie z Kongresu Polskiego Towarzystwa Leczenia Ran\u0000Jubileusz 20-lecia PTLR","authors":"Monika Szymor","doi":"10.5114/lr.2022.122555","DOIUrl":"https://doi.org/10.5114/lr.2022.122555","url":null,"abstract":"","PeriodicalId":130024,"journal":{"name":"Leczenie Ran","volume":"77 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124701533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Silver sulfathiazole (Argosulfan cream) is one of the most commonly used topical drugs for skin burn treatment. The dual mechanism of action of Argosulfan, based on antibacterial activity caused by silver and sulfonamide chemo-therapeutic, provides efficacy in the treatment of wounds at risk of infection and ones that are already infected. This case report shows the efficacy of Argosulfan combined with absorbent dressings in the treatment of IIa and IIb skin burns. The healing was achieved in 16 days, and no adverse events were observed.
{"title":"Silver sulfathiazole in the treatment of burn wounds – case report","authors":"Magdalena Wyrzykowska","doi":"10.5114/lr.2022.122551","DOIUrl":"https://doi.org/10.5114/lr.2022.122551","url":null,"abstract":"Silver sulfathiazole (Argosulfan cream) is one of the most commonly used topical drugs for skin burn treatment. The dual mechanism of action of Argosulfan, based on antibacterial activity caused by silver and sulfonamide chemo-therapeutic, provides efficacy in the treatment of wounds at risk of infection and ones that are already infected. This case report shows the efficacy of Argosulfan combined with absorbent dressings in the treatment of IIa and IIb skin burns. The healing was achieved in 16 days, and no adverse events were observed.","PeriodicalId":130024,"journal":{"name":"Leczenie Ran","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126101863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dariusz Bazaliński, Mateusz Skórka, Paulina Szymańska, Anna Wójcik, Przemysław Lipiński
Over the last decade the medical larvae of Lucilia sericata have been claimed to be “miracle therapeutic maggots” due to their manifold biochemical properties that stimulate healing processes in a wound. Isolating chemical substances from maggot excretions and secretions gives greater possibilities to develop research into the use of defensins to stimulate healing processes in wounds of different aetiologies. Current studies focus on isolation, identification, recombination, and production of selected substances. A critical analysis of literature was done, based on studies published in the years 2000–2022. The authors conducted a review of scientific papers using the PubMed and Termedia databases using the following keywords: defensins, Lucilia sericata , maggot debridement therapy. Lucilia sericata excretions/secretions have proven antibacterial, antibiofilm, anti-inflammatory, and synergistic properties with specific antibiotics effectiveness. Efforts should be made to increase the level of knowledge and engagement among clinicians to implement and recommend MDT not only for biodebridement, but also to stimulate regenerative processes in a wound.
{"title":"Lucilia sericata defensins and their capacity to stimulate wound regenerative processes. A review of the literature and our own observations","authors":"Dariusz Bazaliński, Mateusz Skórka, Paulina Szymańska, Anna Wójcik, Przemysław Lipiński","doi":"10.5114/lr.2022.120200","DOIUrl":"https://doi.org/10.5114/lr.2022.120200","url":null,"abstract":"Over the last decade the medical larvae of Lucilia sericata have been claimed to be “miracle therapeutic maggots” due to their manifold biochemical properties that stimulate healing processes in a wound. Isolating chemical substances from maggot excretions and secretions gives greater possibilities to develop research into the use of defensins to stimulate healing processes in wounds of different aetiologies. Current studies focus on isolation, identification, recombination, and production of selected substances. A critical analysis of literature was done, based on studies published in the years 2000–2022. The authors conducted a review of scientific papers using the PubMed and Termedia databases using the following keywords: defensins, Lucilia sericata , maggot debridement therapy. Lucilia sericata excretions/secretions have proven antibacterial, antibiofilm, anti-inflammatory, and synergistic properties with specific antibiotics effectiveness. Efforts should be made to increase the level of knowledge and engagement among clinicians to implement and recommend MDT not only for biodebridement, but also to stimulate regenerative processes in a wound.","PeriodicalId":130024,"journal":{"name":"Leczenie Ran","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129089361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Specialist dressings for the treatment of infected wounds and those at risk of infection","authors":"","doi":"10.5114/lr.2023.125918","DOIUrl":"https://doi.org/10.5114/lr.2023.125918","url":null,"abstract":"","PeriodicalId":130024,"journal":{"name":"Leczenie Ran","volume":"115 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128211412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Polyhexamethylene biguanide combined with poloxamer 188 in the local treatment of chronic wounds of vascular aetiology – own experience and practice","authors":"Dariusz Bazaliński, Paulina Szymańska, Mateusz Skórka","doi":"10.5114/lr.2021.111070","DOIUrl":"https://doi.org/10.5114/lr.2021.111070","url":null,"abstract":"","PeriodicalId":130024,"journal":{"name":"Leczenie Ran","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133158532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Levels of pain, anxiety, and depression in patients with peripheral arterial disease","authors":"R. Piotrkowska, P. Jarzynkowski, Ada Wołowik","doi":"10.5114/lr.2021.107146","DOIUrl":"https://doi.org/10.5114/lr.2021.107146","url":null,"abstract":"","PeriodicalId":130024,"journal":{"name":"Leczenie Ran","volume":"263 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133697686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cathelicidin – what’s new in the treatment of chronic wounds?","authors":"T. Grzela","doi":"10.5114/lr.2021.107148","DOIUrl":"https://doi.org/10.5114/lr.2021.107148","url":null,"abstract":"","PeriodicalId":130024,"journal":{"name":"Leczenie Ran","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123724990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Arletta Kozłowska, A. Surówka, A. Jaworek, A. Wojas-Pelc
Pyoderma gangrenosum (PG) is a rare, potentially fatal skin disease with the formation of a painful, rapidly progressing (dynamic) necrotic ulcer with undermined blue-violet margins. PG in 50-70% of patients coexists with other systemic diseases: inflammatory bowel diseases (most frequent), arthritis (most often rheumatoid arthritis – RA), cancer of internal organs, myeloproliferative syndromes
{"title":"Pyoderma gangrenosum in a patient with Down syndrome","authors":"Arletta Kozłowska, A. Surówka, A. Jaworek, A. Wojas-Pelc","doi":"10.5114/lr.2022.122552","DOIUrl":"https://doi.org/10.5114/lr.2022.122552","url":null,"abstract":"Pyoderma gangrenosum (PG) is a rare, potentially fatal skin disease with the formation of a painful, rapidly progressing (dynamic) necrotic ulcer with undermined blue-violet margins. PG in 50-70% of patients coexists with other systemic diseases: inflammatory bowel diseases (most frequent), arthritis (most often rheumatoid arthritis – RA), cancer of internal organs, myeloproliferative syndromes","PeriodicalId":130024,"journal":{"name":"Leczenie Ran","volume":"49 4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130885959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mariola Sibilska, Diana Markowska, Katarzyna Zadka, Gabriela Terlicka, W. Knapczyk
{"title":"The use of immunomodulating diet in the treatment of pressure ulcers in elderly – case report","authors":"Mariola Sibilska, Diana Markowska, Katarzyna Zadka, Gabriela Terlicka, W. Knapczyk","doi":"10.5114/lr.2021.112210","DOIUrl":"https://doi.org/10.5114/lr.2021.112210","url":null,"abstract":"","PeriodicalId":130024,"journal":{"name":"Leczenie Ran","volume":"455 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122780012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：